MD-224

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMD-224
Drug Alias NameMD-224
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of Actionp53-binding protein Mdm-2 inhibitorsProteolysis
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A